Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
CONTEXT: Targeted secretion inhibitors (TSIs), a new class of recombinant biotherapeutic proteins engineered from botulinum toxin, represent a novel approach for treating diseases with excess secretion. They inhibit hormone secretion from targeted cell types through cleavage of SNARE (soluble N-ethy...
Main Authors: | Garcia, E, Trivellin, G, Aflorei, E, Powell, M, Grieve, J, Alusi, G, Pobereskin, L, Shariati, B, Cudlip, S, Roncaroli, F, Mendoza, N, Grossman, AB, Harper, E, Korbonits, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.
by: Trivellin, G, et al.
Published: (2010) -
Acromegaly with no pituitary adenoma and no evidence of ectopic source
by: Deepak Khandelwal, et al.
Published: (2011-01-01) -
Oncogene-induced senescence in pituitary adenomas and carcinomas.
by: Alexandraki, K, et al.
Published: (2012) -
Two synchronous pituitary adenomas causing Cushing's Disease and acromegaly
by: Schorr, M, et al.
Published: (2019) -
Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
by: Preda, V, et al.
Published: (2014)